Sector: Pharmaceuticals & Biotechnology

Large Cap

Laurus Labs Share Price

Laurus Labs Ltd.

₹1,343.50

0.00(0.00%)

Invest in LAURUSLABS with up to 3.57x margin.

Trade with MTF

22nd May 2026 | 3:29 PM

NSE : LAURUSLABS

Open Free Demat Account

Laurus Labs Performance

Price Movement

₹1343.50

₹1332.10

₹1355.70

↘ Today's Low↗ Today's High

1 Year Performance

₹1343.50

₹584.50

₹1373.90

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹1,355.70

Low₹1,332.10

Open at₹1,355.70

Prev Close₹1,343.50

Volumes16.99 L

Avg Price₹1,343.47

Lower Circuit₹1,209.20

Upper Circuit₹1,477.80

Historical Performance

3M High₹1,363.40

3M Low₹936.30

1 Yr High₹1,363.40

1 Yr Low₹584.50

3 Yr High₹1,363.40

3 Yr Low₹309.60

5 Yr High₹1,363.40

5 Yr Low₹278.85

Laurus Labs Fundamentals

Market Cap

High in industry

72,529.70 Cr.

PE Ratio (TTM)

High in industry

81.60

Dividend Yield

Low in industry

0.10

Net Profit TTM

148.0% incr over last year

888.79

Net Profit Growth

148.0% incr over last year

888.79

PEG Ratio

Above industry Median

0.60

ROE

109.2% incr over last year

16.76

Operating Revenue TTM

6,812.90

Operating Revenue Growth

22.7% incr over last year

Book Value

High in industry

14.30

MFI

MFI strongly Overbought

90.51

RSI

RSI strongly Overbought

81.89

EPS (TTM)

16.47

Debt to Equity

0.45

Face Value

Operating Profit Margin Qtr.

25.88

Operating Profit Qtr.

512.11

Net Profit Qtr.

279.14

Operating Revenue Qtr.

1,811.57

PB Ratio

14.30

Laurus Labs Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Revenue	1,580.30	1,509.42	1,566.60	1,432.75	1,650.01
Operating Expense	1,204.94	1,163.56	1,176.94	1,105.37	1,255.17
Operating Profit	375.36	345.86	389.66	327.38	394.84
Depreciation	95.17	94.31	95.59	93.57	88.19
Interest	33.91	31.48	33.68	43.89	48.61
Tax	67.58	59.36	73.17	53.50	78.30
Net Profit	191.79	175.08	215.67	157.94	251.90

Laurus Labs Technicals

Laurus Labs Ltd. EMA & SMA

₹1343.50

-7.50 (-0.56%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹1315.9

Day EMA10 ₹1277.3

Day EMA12 ₹1263.8

Day EMA20 ₹1220.8

Day EMA26 ₹1196.8

Day EMA50 ₹1138.2

Day EMA100 ₹1077.6

Day EMA200 ₹986.6

Laurus Labs Support and Resistance

Resistance

First Resistance₹1357.97

Second Resistance₹1371.03

Third Resistance₹1388.97

Support

First Support₹1326.97

Second Support₹1309.03

Third Support₹1295.97

Technical Indicators

Day RSI81.89

Day MFI90.51

Day ADX37.74

Day Commodity Channel Index126.30

William-3.00

Day MACD67.03

Day MACD Signal Line53.10

Day ATR34.74

Day ROC12534.89

Day ROC2118.42

Laurus Labs Shareholding Pattern

Held By	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoter	27.6	27.6	27.6	27.6	27.5	27.5
FII	25.6	25.5	25.7	26.2	26.5	25.8
DII	12.7	11.8	11.9	11.7	12.4	14
Public	34.1	35.1	34.2	34.5	33.6	32.7

Laurus Labs Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	11.67 L	19.85 L	58.79%
Week	13.38 L	25.46 L	52.56%
1 Month	13.48 L	26.13 L	51.59%
6 Month	9.93 L	19.61 L	50.66%

Laurus Labs SWOT Analysis

Strengths30

Weakness8

Opportunity7

Threats1

Growth Factor Screener: Rising returns on equity (ROE), Momentum, and Earnings Yield

Benjamin Graham Value Screen

Strong Performer, Getting Expensive (DVM)

Companies with 10% increase in share price over three months, with rising net profit growth

Strong Momentum: Price above short, medium and long term moving averages

Consistent high performing stocks over Five Years

Relative Outperformance versus Industry over 1 Month

Rising Net Cash Flow and Cash from Operating activity

Growth Stars: Strongest Annual EPS Performers

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Overbought by Money Flow Index (MFI)

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Increasing Revenue every quarter for the past 3 quarters

Increasing profits every quarter for the past 3 quarters

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Near 52 Week High

Stock gained more than 20% in one month

Highest Recovery from 52 Week Low

Stocks near 52 Week High with Significant Volumes

Stocks Outperforming their Industry Price Change in the Quarter

Laurus Labs Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
08 May, 2026	1.2	INTERIM	08 May, 2026	Equity Share
31 Oct, 2025	0.8	INTERIM	31 Oct, 2025	Equity Share
09 May, 2025	0.8	INTERIM	09 May, 2025	Equity Share
06 Nov, 2024	0.4	INTERIM	06 Nov, 2024	Equity Share
08 May, 2024	0.4	INTERIM	08 May, 2024	Equity Share
02 Nov, 2023	0.4	INTERIM	02 Nov, 2023	Equity Share
10 May, 2023	1.2	INTERIM	10 May, 2023	Equity Share
03 Nov, 2022	0.8	INTERIM	04 Nov, 2022	Equity Share
10 May, 2022	1.2	INTERIM	11 May, 2022	Equity Share
17 Nov, 2021	0.8	INTERIM	18 Nov, 2021	Equity Share

Laurus Labs Stock Comparison

Financials	Sai Life Science Ltd.	OneSource Specialty Pharma Ltd.	Emcure Pharmaceuticals Ltd.	Mankind Pharma Ltd.	Piramal Pharma Ltd.	Acutaas Chemicals Ltd.
Price (₹)	₹1,106	₹1,824.80	₹1,715	₹2,479.40	₹175.01	₹2,953.20
% Change	-0.70%	-0.53%	0.08%	-0.00%	-0.35%	0.07%
Revenue TTM (₹ Cr)	₹2,192.49	₹1,421.59	₹9,203.54	₹14,277.64	₹8,869.07	₹1,339.37
Net Profit TTM (₹ Cr)	₹348.91	₹-73.80	₹924.36	₹1,912.93	₹-325.93	₹356.26
PE TTM	69.40	-290.10	35.60	55.80	-71.90	66.20
1 Year Return	52.37	14.63	61.15	0.77	-14.16	142.29
ROCE	18.38	0.59	25.65	13.27	2.29	27.72

Similar Stocks

GLAND

Gland Pharma Ltd.

₹ 2334.00

+0.00%

ALKEM

Alkem Laboratories Ltd.

₹ 5414.00

+0.18%

BIOCON

Biocon Ltd.

₹ 429.90

-0.08%

DIVISLAB

Divi's Laboratories Ltd.

₹ 6900.00

+0.19%

AJANTPHARM

Ajanta Pharma Ltd.

₹ 3118.00

+0.34%

ZYDUSLIFE

Zydus Lifesciences Ltd.

₹ 1038.60

-0.03%

GLENMARK

Glenmark Pharmaceuticals Ltd.

₹ 2259.10

+0.00%

WOCKPHARMA

Wockhardt Ltd.

₹ 1577.00

+0.10%

AUROPHARMA

Aurobindo Pharma Ltd.

₹ 1468.00

+0.31%

NATCOPHARM

Natco Pharma Ltd.

₹ 1170.00

+0.03%

SUNPHARMA

Sun Pharmaceutical Industries Ltd.

₹ 1844.60

+0.00%

NEULANDLAB

Neuland Laboratories Ltd.

₹ 16681.00

-0.07%

IPCALAB

Ipca Laboratories Ltd.

₹ 1603.50

+0.09%

JBCHEPHARM

J B Chemicals & Pharmaceuticals Ltd.

₹ 2190.30

-0.10%

ASTRAZEN

AstraZeneca Pharma India Ltd.

₹ 8577.00

-0.12%

GLAXO

GlaxoSmithKline Pharmaceuticals Ltd.

₹ 2313.90

+0.30%

PFIZER

Pfizer Ltd.

₹ 4659.30

-0.25%

ABBOTINDIA

Abbott India Ltd.

₹ 27855.00

+0.09%

TORNTPHARM

Torrent Pharmaceuticals Ltd.

₹ 4497.00

+0.24%

LUPIN

Lupin Ltd.

₹ 2270.70

-0.49%

DRREDDY

Dr. Reddy's Laboratories Ltd.

₹ 1310.00

+0.21%

CIPLA

Cipla Ltd.

₹ 1399.20

+0.00%

FAQ's on LAURUSLABS

What is the current share price of Laurus Labs Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Laurus Labs Ltd. is ₹ 1343.5 on the NSE and ₹ 1343.4 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Laurus Labs Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Laurus Labs Ltd. is approximately ₹ 72529.7 Cr.

What are the PE and PB ratios for Laurus Labs Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Laurus Labs Ltd. is 81.6, and the Price-to-Book (PB) ratio is 14.3.

What is the 52-Week High and Low for Laurus Labs Ltd.?

Over the past 52 weeks, the highest price reached by Laurus Labs Ltd. shares was ₹ 1363.4, and the lowest price was ₹ 584.5.

What is the current dividend yield for Laurus Labs Ltd.?

As of 6 June 2025, the dividend yield for Laurus Labs Ltd. is 0.1%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.

Who are the major shareholders of Laurus Labs Ltd.?

Significant shareholdings in Laurus Labs Ltd. typically include entities such as:

Public
Promoter
FII
Mutual Funds
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Laurus Labs Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Laurus Labs Ltd. is often compared with other major players such as Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories and Vivimed Labs for analysis and benchmarking.

What is the latest dividend information for Laurus Labs Ltd.?

Laurus Labs Ltd. last declared a INTERIM dividend of ₹ 1.2 per share for the financial period ending 2026. The record date was set as 2026-05-08, and the payment was/is scheduled around 2026-05-08. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy